Citadel Advisors »

Nrx Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Nrx Pharmaceuticals (NRXP) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Nrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Nrx Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nrx Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $61k 36k 1.69
2024-06-30 $57k 23k 2.44

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Nrx Pharmaceuticals

Vanguard Group
Frigate Ventures
AdvisorShares Investments
Geode Capital Management
Citadel Advisors
BlackRock
BlackRock
Susquehanna International
Virtu Financial
State Street Corporation
One Wealth Management Investment & Advisory Services
Townsquare Capital
Morgan Stanley
Tower Research Capital
Bank of America Corporation

View all funds holding Nrx Pharmaceuticals